- A plain language summary of results from the FLAURA2 study: Initial (…
Number of the records: 1  

A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC

  1. TitleA plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC / Planchard D., Andrasina I. ... [et al.]
    Another responsib. Andrašina, Igor, 1955- (Bibliographic antecedent)
    Redakcia Onkológia (Adapter)
    NoteFuture Oncol. 2025 Feb 24, 217:115255
    In Onkológia. -- ISSN 1336-8176. -- Roč. 20, č. 1 (2025), s. 63-64
    Call numberC 3069
    MeSH Subject karcinóm pľúc, nemalobunkový
    receptory erbB
    antineoplastiká imunologické
    inhibítory tyrozínkináz
    štúdie klinické ako téma
    Keywords osimertinib * štúdia FLAURA2 * 1. línia liečby
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.